Search research articles
Contact Us
Filters
Showing results (31-40 of 128) with videos related to
Page
of 13
Sort By:
Diabetes Research and Clinical Practice
|
July 28, 2017
Continuous glucose monitoring detected hypoglycaemia in the Treating to Target in Type 2 Diabetes Trial (4-T)
J C Levy, M J Davies, R R Holman, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
January 22, 2005
Framingham risk equations underestimate coronary heart disease risk in diabetes
R J Stevens, R L Coleman, R R Holman
Diabetologia
|
February 12, 2013
Metformin and mortality. Reply to Lund SS [letter]
R J Stevens, B J Cairns, R R Holman
Diabetes Care
|
June 26, 2001
Relationship between ethnicity and glycemic control, lipid profiles, and blood pressure during the first 9 years of type 2 diabetes: U.K. Prospective Diabetes Study (UKPDS 55)
T M Davis, C A Cull, R R Holman, et al.
British Medical Journal (Clinical Research Ed.)
|
December 21, 1985
The Christmas feast
S G Rees, R R Holman, R C Turner
Diabetes Care
|
February 1, 1996
U.K. prospective diabetes study
R C Tubner, C A Cull, R R Holman
Diabetic Medicine : a Journal of the British Diabetic Association
|
November 26, 2013
Ethnicity and long-term vascular outcomes in Type 2 diabetes: a prospective observational study (UKPDS 83)
T M E Davis, R L Coleman, R R Holman, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
December 1, 2004
Changing aspirin use in patients with Type 2 diabetes in the UKPDS
C A Cull, H A W Neil, R R Holman
British Medical Journal
|
May 3, 1980
Fasting blood glucose concentrations and treatment of maturity-onset diabetes
S Howe-Davies, A Muir, R R Holman, et al.
Diabetes Care
|
January 1, 1987
No glycemic benefit from guar administration in NIDDM
R R Holman, J Steemson, P Darling, et al.
Page
of 13
Search research articles
Search
Showing results (31-40 of 128) with videos related to
Sort By:
Page
of 13
Diabetes Research and Clinical Practice
|
July 28, 2017
Continuous glucose monitoring detected hypoglycaemia in the Treating to Target in Type 2 Diabetes Trial (4-T)
J C Levy, M J Davies, R R Holman, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
January 22, 2005
Framingham risk equations underestimate coronary heart disease risk in diabetes
R J Stevens, R L Coleman, R R Holman
Diabetologia
|
February 12, 2013
Metformin and mortality. Reply to Lund SS [letter]
R J Stevens, B J Cairns, R R Holman
Diabetes Care
|
June 26, 2001
Relationship between ethnicity and glycemic control, lipid profiles, and blood pressure during the first 9 years of type 2 diabetes: U.K. Prospective Diabetes Study (UKPDS 55)
T M Davis, C A Cull, R R Holman, et al.
British Medical Journal (Clinical Research Ed.)
|
December 21, 1985
The Christmas feast
S G Rees, R R Holman, R C Turner
Diabetes Care
|
February 1, 1996
U.K. prospective diabetes study
R C Tubner, C A Cull, R R Holman
Diabetic Medicine : a Journal of the British Diabetic Association
|
November 26, 2013
Ethnicity and long-term vascular outcomes in Type 2 diabetes: a prospective observational study (UKPDS 83)
T M E Davis, R L Coleman, R R Holman, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
December 1, 2004
Changing aspirin use in patients with Type 2 diabetes in the UKPDS
C A Cull, H A W Neil, R R Holman
British Medical Journal
|
May 3, 1980
Fasting blood glucose concentrations and treatment of maturity-onset diabetes
S Howe-Davies, A Muir, R R Holman, et al.
Diabetes Care
|
January 1, 1987
No glycemic benefit from guar administration in NIDDM
R R Holman, J Steemson, P Darling, et al.
Page
of 13